BioAge Labs (BIOA) Accumulated Expenses (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Accumulated Expenses data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 5.76% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 5.76% YoY), and the FY2025 full-year result was $4.4 million, down 62.96% from the prior year.
• Accumulated Expenses declined to $1.6 million in Q1 2026, from $4.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.8 million in Q4 2024 to a low of $1.5 million in Q1 2025.
• A 4-year average of $5.9 million and a median of $5.8 million in 2025 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 48.03% in 2024 and tumbled 62.96% in 2025, its largest moves.
• Tracing BIOA's Accumulated Expenses over 4 years: stood at $7.9 million in 2023, then surged by 48.03% to $11.8 million in 2024, then sank by 62.96% to $4.4 million in 2025, then plunged by 62.89% to $1.6 million in 2026.
• Business Quant data shows BIOA's Accumulated Expenses at $1.6 million in Q1 2026, $4.4 million in Q4 2025, and $7.3 million in Q3 2025.